Display options
Share it on

Psychiatry Investig. 2017 May;14(3):380-382. doi: 10.4306/pi.2017.14.3.380. Epub 2017 May 16.

Tardive Dystonia Related with Aripiprazole.

Psychiatry investigation

Sunghwan Kim, Seung-Yup Lee, MinSeob Kim, Kyoung-Uk Lee

Affiliations

  1. Department of Psychiatry, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea.

PMID: 28539959 PMCID: PMC5440443 DOI: 10.4306/pi.2017.14.3.380

Abstract

Tardive dystonia is characterized by sustained, generally slow involuntary twisting movements. It is estimated to occur at a frequency of 1% to 4% among patients who are taking an antipsychotic agent. Unlike the first generation antipsychotics, the second generation antipsychotics are less likely to cause neuroleptic-induced movement disorder. For aripiprazole, only a few cases have been reported for tardive dystonia. We present a young male, who developed a severe tardive dystonia after taking aripiprazole for 5 years. The patient was admitted to for the treatment of both hisdystonic and psychotic symptoms. Olanzapine was administered instead of aripiprazole and while his psychotic symptoms improved, the dystonic symptoms were continued. Therefore, olanzapine was switched to clozapine while augmenting with benzodiazepine, anti-cholinergic, and ginko biloba to control his tardive dystonia. After 2 weeks of treatment, the dystonic movement decreased remarkably.

Keywords: Aripiprazole; Clozapine; Ginkgo biloba; Schizoaffective disorder; Tardive dystonia

References

  1. Handb Clin Neurol. 2011;100:601-16 - PubMed
  2. J Clin Psychiatry. 2010 May;71(5):652-3 - PubMed
  3. J Clin Psychopharmacol. 2012 Apr;32(2):297-8 - PubMed
  4. Clin Neuropharmacol. 2010 Nov-Dec;33(6):271-5 - PubMed
  5. P T. 2008 Jan;33(1):32-4 - PubMed
  6. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):589-90 - PubMed
  7. Expert Opin Pharmacother. 2012 Aug;13(11):1587-98 - PubMed
  8. Psychiatry Clin Neurosci. 2010 Jun;64(3):337-8 - PubMed
  9. Neuropsychopharmacology. 2003 Aug;28(8):1400-11 - PubMed
  10. J Clin Psychiatry. 2011 Aug;72(8):1063-71 - PubMed
  11. CNS Spectr. 2006 Jun;11(6):435-9 - PubMed
  12. Ann Pharmacother. 2005 Nov;39(11):1953 - PubMed
  13. Biol Psychiatry. 1999 Mar 15;45(6):715-30 - PubMed
  14. Clin Psychopharmacol Neurosci. 2014 Apr;12(1):69-71 - PubMed
  15. BMC Psychiatry. 2015 Oct 19;15:253 - PubMed
  16. J Clin Psychopharmacol. 1997 Apr;17(2):88-91 - PubMed
  17. Am J Psychiatry. 1991 Aug;148(8):1055-9 - PubMed
  18. Psychiatr Clin North Am. 2005 Mar;28(1):255-74, x - PubMed
  19. J Clin Psychopharmacol. 2013 Oct;33(5):675-81 - PubMed
  20. Neurology. 1982 Dec;32(12):1335-46 - PubMed
  21. J Clin Psychopharmacol. 2015 Feb;35(1):13-21 - PubMed
  22. Schizophr Bull. 1999;25(4):741-8 - PubMed
  23. Neurology. 2013 Jul 30;81(5):463-9 - PubMed
  24. J Neuropsychiatry Clin Neurosci. 2006 Summer;18(3):426-7 - PubMed
  25. J Clin Psychopharmacol. 2012 Aug;32(4):563-4 - PubMed
  26. Mov Disord. 1994 Jul;9(4):441-6 - PubMed
  27. Postgrad Med. 2015;127(7):726-37 - PubMed
  28. J Clin Psychopharmacol. 2007 Oct;27(5):525-6 - PubMed

Publication Types